BioSpace News Archive

Wilmington, Delaware, United States: Childbearing at an early age has become an issue of concern and to prevent the deaths caused due to this aspect, contraceptives are essential.

Wilmington, Delaware, United States: According to the report, the global newborn screening market was valued at ~US$ 940 Mn in 2019 and is projected to expand at a CAGR of ~11% from 2021 to 2031.

Innate Pharma SA announced that its investor relation team will participate in the following upcoming investor conference.

DEM BioPharma, Inc. announced its initial $70 million financing led by founding investor Longwood Fund and Alta Partners, with additional participation from Insight Partners, Pfizer Ventures, Astellas Venture Management, Emerson Collective, UTokyo Innovation Platform and Alexandria Venture Investments.

John C. Byrd, M.D., Renowned Cancer Clinician and Researcher, Named Chair of Scientific Advisory Board.

Renalytix plc (NASDAQ: RNLX) (LSE: RENX) today announced the Company will report its third quarter fiscal 2022 financial results on Thursday, June 30, 2022, before market open.

With New Leadership, Company Set to Accelerate Technology & Product Excellence and Expand its Offerings.

Omega Therapeutics, Inc. (Nasdaq: OMGA) (“Omega”), a development-stage biotechnology company pioneering the first systematic approach to use mRNA therapeutics as a new class of programmable epigenetic medicines by leveraging its OMEGA Epigenomic Programing™ platform, today announced that it will present preclinical data for OTX-2002 Conference.

Ad-Tech Medical, an ArchiMed portfolio company, and the country’s leading manufacturer of neuro electrodes today announced that Joshua Rodebaugh has joined the company’s clinical support and sales team.

Retail Comparable Store Prescriptions Increased 0.9 Percent – Comparable Store Non-COVID Acute Prescriptions Increased 11.9 Percent.